Association Between the rs538089 of the LMNA Gene and Dilated Cardiomyopathy in Iranian Patients

Document Type: Original Article

Authors

1 Department of Biology, Islamic Azad University, Central Tehran Branch, Tehran, IR Iran.

2 Department of Cardiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran.

Abstract

Background: Dilated cardiomyopathy (DCM) is one of the most common causes of heart failure. More than 40 genes with different strengths are involved in its pathogenesis. The second most important gene in DCM pathogenesis is the LMNA gene. LMNA has 12 exons and encodes Lamin A and Lamin C. This study aimed to screen any mutation that occurs in exons 4 and 5 of this gene in patients suffering from DCM.
 
Methods: Thirty patients with DCM were enrolled in this study. A control group was formed from 30 normal participants. After DNA extraction, polymerase chain reaction (PCR) was performed to amplify desired DNA fragments. Then, the amplified fragments were sequenced via the Sanger technique. The obtained sequences were statistically analyzed using the SPSS software, version 24.
 
Results: In exon 5, in 23.3% (n = 7) of the patients, 1 substitution mutation (c.861 T>C; rs538089) was detected. All the patients were heterozygous for this variant. The frequency for mutated alleles was significantly higher in the patients than in the normal controls (χ2 = 4.821; P = 0.028). No mutation was observed in exon 4 both in the patient and control groups.
 
Conclusions: Although rs538089 is a synonymous mutation, its predominant existence in the LMNA gene of our patients was interesting, as was its association with the female gender. It could be assumed that this variant may play a potential role in DCM. (Iranian Heart Journal 2020; 21(4): 103-110)
 

Highlights

 

 

Keywords


 

 
  1. Braunwald E. Cardiomyopathies: An Overview. Circ Res 2017; 121(7):711–21.
  2. McNally EM, Mestroni L. Dilated Cardiomyopathy: Genetic Determinants and Mechanisms. Circ Res 2017; 121(7):731–48.
  3. Haas J, Frese KS, Peil B, Kloos W, Keller A, Nietsch R et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J 2015; 36(18):1123-35a.
  4. Japp AG, Gulati HA, Cook SA, Cowie MR, Prasad SK. The Diagnosis and Evaluation of Dilated Cardiomyopathy. JOU RNAL OF THE AME R I CAN COL L EG E OF CARD I OLOGY 2016; 67(25):0 7 3 5 - 1 0 9 7.
  5. Tayal U, Prasad S, Cook SA. Genetics and genomics of dilated cardiomyopathy and systolic heart failure. Genome Med 2017; 9(1):20.
  6. Lakdawala NK, Winterfield Jeffery R., Funke Birgit H. Dilated Cardiomyopathy. Circ Arrhythm Electrophysiol. 2013; 6(1):228–37.
  7. Broch K, Andreassen AK, Hopp E, Leren TP, Scott H, Müller F et al. Results of comprehensive diagnostic work-up in 'idiopathic' dilated cardiomyopathy. Open Heart 2015; 2(1):e000271.
  8. Mestroni L, Brun F, Spezzacatene A, Sinagra G, Taylor MR. GENETIC CAUSES OF DILATED CARDIOMYOPATHY. Prog Pediatr Cardiol 2014; 37(1-2):13–8.
  9. Kinnamon DD, Morales A, Bowen DJ, Burke W, Hershberger RE. Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study. Circ Cardiovasc Genet 2017; 10(6).
  10. Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med 2014; 16(8):601–8.
  11. Parvari R, Levitas A. The mutations associated with dilated cardiomyopathy. Biochem Res Int 2012; 2012:639250.
  12. Pérez-Serra A, Toro R, Sarquella-Brugada G, Gonzalo-Calvo D de, Cesar S, Carro E et al. Genetic basis of dilated cardiomyopathy. Int J Cardiol 2016; 224:461–72.
  13. Tobita T, Nomura S, Fujita T, Morita H, Asano Y, Onoue K et al. Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. Sci Rep 2018; 8(1):1998.
  14. Kapoor M, Seth S, Rao V. Clinical genetic aspects of cardiomyopathies. J Pract Cardiovasc Sci 2015; 1(2):120.
  15. El-Hattab AW, Scaglia F. Mitochondrial Cardiomyopathies. Front Cardiovasc Med 2016; 3:25.
  16. Ollila L, Nikus K, Holmström M, Jalanko M, Jurkko R, Kaartinen M et al. Clinical disease presentation and ECG characteristics of LMNA mutation carriers. Open Heart 2017; 4(1):e000474.
  17. Botto N, Vittorini S, Colombo MG, Biagini A, Paradossi U, Aquaro G et al. A novel LMNA mutation (R189W) in familial dilated cardiomyopathy: Evidence for a 'hot spot' region at exon 3: a case report. Cardiovasc Ultrasound 2010; 8:9.
  18. Reunert J, Wentzell R, Walter M, Jakubiczka S, Zenker M, Brune T et al. Neonatal progeria: increased ratio of progerin to lamin A leads to progeria of the newborn. Eur J Hum Genet 2012; 20(9):933–7.
  19. Zahr HC, Jaalouk DE. Exploring the Crosstalk Between LMNA and Splicing Machinery Gene Mutations in Dilated Cardiomyopathy. Front Genet 2018; 9:231.
  20. Brayson D, Shanahan CM. Current insights into LMNA cardiomyopathies: Existing models and missing LINCs. Nucleus 2017; 8(1):17–33.
  21. Lu JT, Muchir A, Nagy PL, Worman HJ. LMNA cardiomyopathy: Cell biology and genetics meet clinical medicine. Dis Model Mech 2011; 4(5):562–8.
  22. Rogozhina Y, Mironovich S, Shestak A, Adyan T, Polyakov A, Podolyak D et al. New intronic splicing mutation in the LMNA gene causing progressive cardiac conduction defects and variable myopathy. Gene 2016; 595(2):202–6.
  23. Marian AJ, van Rooij E, Roberts R. Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders. JOURNAL OF T H E AMERICAN COL LE GE OF CARD IOLOGY 2016; 68(25):2831–49.
  24. Richardson P, McKenna R, Bristow M, Maisch B, Mautner B, O'connell J et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of car diomyopathies. Circulation 1996; 93(5):841–2.
  25. Araco M, Merlo M, Carr-White G, Sinagra G. Genetic bases of dilated cardiomyopathy. J Cardiovasc Med (Hagerstown) 2017; 18(3):123–30.
  26. Perrot A, Hussein S, Ruppert V, Schmidt HHJ, Wehnert MS, Duong NT et al. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. Basic Res Cardiol 2009; 104(1):90–9.
  27. Millat G, Chanavat V, Julia S, Crehalet H, Bouvagnet P, Rousson R. Validation of high-resolution DNA melting analysis for mutation scanning of the LMNA gene. Clin Biochem 2009; 42(9):892–8.
  28. Banerjee A, Ghoshal PK, Sengupta K. Novel linkage of LMNA Single Nucleotide Polymorphism with Dilated Cardiomyopathy in an Indian case study. Int J Cardiol Heart Vasc. 2015; 7:99–105.